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PLEASE READ INSTRUCTIONS ON REVERSE BEFORE COMPLETING 
PART I—PROJECT IDENTIFICATION INFORMATION 
1. Institution and Address 
Georgia Institute of Technology 
Atlanta, Georgia 30332 
2. NSF Program 
i ineerng Eng eer
3. NSF Award Number 
ENG77-17233 	• 
4. Award Period 
From 9/1/77 	To 2/28/79 
5. Cumulative Award Amount 
$19,300 
6. Project Title 
"Equipment for Instrumentation and Experimentation in Heart-Muscle Mechanics". 
PART H—SUMMARY OF COMPLETED PROJECT (FOR PUBLIC USE) 
An experimental system for the studies of the mechanical and optical properties 
of heart muscle is designed and constructed. 
The system consists of four major subsystems, i.e., environmental, mechanical, 
optical and control systems. 	The environmental system provides control of the pH, 
p02, temperature and programmed electric stimulation of the specimen. 	To cope with 
the rapidly and continuously changing active state of heart muscle, a fast close-
looped, electro-mechanical system is designed with a steady state rise time of 100 
microseconds. 	(Comparable to the huxley's of 400 microseconds). 
The optic system consists of a laser and accessories which measures muscle length 
without artifact introduced by damages ends, and birefringence due to muscular 
activity. 	The control system consists of a minicomputer and accessory I/O devices 
used to monitor and control the movement of the mechanical system, pH, temperature 
and stimulation; it also monitors p02 , displacement and force data via special purpose 
digital processing units. 
As a by-product, an optic probe for the viability of myocardium is invented. 
PART 111—TECHNICAL INFORMATION (FOR PROGRAM MANAGEMENT USES) 
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ITEM (Check appropriate blocks) NONE ATTACHED PREVIOUSLY FURNISHED 
TO BE FURNISHED 
SEPARATELY TO PROGRAM 
Check ( ✓ ) Approx. Date 
a. Abstracts of Theses 
b. Publication Citations 	 . X 
c. Data on Scientific Collaborators 
d. Information on Inventions 
e. Technical Description of Protect and Results Jan. 	1981 
f. Other (specify) \\ 
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2. Principal Investigator/Project Director Name (Typed) 
Hyland Y. L. Chen 
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"••1ECORD - OF INVENTION - Part I 
This is an important legal document. Read instructions carefully before filling in data. 
PROJECT NO. 
     
     
RECOMMENDED SECURITY 






I. NAME OF INVENTOR 	 POSITION 
Hyland Y. L. Chen 	 Assistant Professor 
2. DEPARTMENT OR DIVISION 
ESM Department, Georgia Institute of Technology 
3. DALES OF EmPLOTMEN1 
1973-date 
     
4. PRESEN ■ ADDRESS ( No. Street, City, County, Slate) 





PERMANENT OR UNTIL 
   
5. PERMANENTA 0DRESS(No.bime,ComMy.SWW 
ESM, Ga. - Tech, Atlanta, Georgia 30332 
   
TELEPHONE 
894-2790 
6. NALIES (5) AND ADDRESS 1E51 OF CO. INVENTORS ( (( any ) 
N/A 
    
7. DESCRIPTIVE TITLE OF INVENTION 
An Optic Probe for the viability of Myocardium 
8. LIST DRAWINGS. SKETCHES. PHOTOS. REPORTS. DESCRIPTIONS. NOTEBOOK ENTRIES. ETC. WHICH SHOW OR DESCRIBE INVENTION 
A schematic is attached for this report 
9. EARLIEST DATA AND PLACE INVENTION WAS CONCEIVED (Brief outline of DIrcumatctncws) 
Ga. Tech, Sept., 1975. During the design of an optical system to avoid the "damaged 
end" artifact in heart muscle research I saw that laser light had been used in the 
sense of illumination by Hefner and of Fourier waves by Pollack. Continuing this 
line of thought, I saw that by using laser light as an electromagnetic wave, a device 
10. DATAND PLACE OF FIRST SKETCH. DRAWING DR PHOTO 
n/a 	 to test the viability of myocardium in situ could be developed 
11. OAT O AND PLACE OF FIRST WRITTEN DESCRIPTION 
n/a 
12. DISCLOSURE  OF INVENTION TO OTHERS 
NAME, TITLE AND ADDRESS 
FORM OF 
DISCLOSURE 




(YES OR NO) 
Dr. Y. C. Fung, Professor, AMES-Bioengineering around Dec., 1975 no 
UGSD LaJolla, Calif. 	92093 discussion 
Dr. Allen Brady, Professor, Dept. of 
Physiology, UCLA. LA, Calif. discussionoList De 
 around.Dec . 	1976 
contlnued, 
no 
12.A IMPORTANT . HAVE ANY PUBLICATIONS OR REPORTS BEEN MADE ON THIS INVENTION? 
no. 
13. DATE AND PLACE OF COmPEET Wt. OF FIRST OPERATING MODEL OR FULL SIZE DEVICE 
N/A 
14. PRESENT LOCATION OF MODEL 	
N/A 
15. DATE. PLACE. DESCRIPTION ANO RESULTS OF FIRST TEST OR OPERATION 
NONE 
Form EES 304 Pugs 1 
12. 
	
DISCLOSURE OF INVENTION TO OTHERS 
NAME, TITLE AND ADDRESS 
FORM of 
DISCLOSURE 




(YES OR NO) 
Dr. Robert Schlant, Head, Dept. of Cardiolov, 
..• 	 - 	G 	. 	- 	• ll 1 	early 1977 no 
Dr. . L. 	Hefner, Professor, Dept. o 	Car•i. 
17101 	Rirmingham 	Alabama 
ogy 
discussion mid 1977 no 
Dr. Steve Yandle, Naval Medical Research Cn 
11‘.th ,nd.1, MD discussion Feb. 	1979 no 
Dr. Newman Stevens, Professor, Univ. of Win epeg, Canada 




	 DISCLOSURE OF INVENTION TO OTHERS 
NAME, TITLE ANO ADDRESS 
FORM OF 
DISCLOSURE 




(YES OR NO) 
Dr. Jonn Lundberg, Professor, Textile •nginaering 
Georgia Tech discussion 
around 
early 1976 no 
Dr,, B. Zimm 	Profess 	of Chemistry 
uCsD 	La Jolla, Californiat 	92093 discussion January, 	1977 no 
Dr. T. Donaids, Cardiology 
UAB 	Birmingham, Alabama discussion around 1977 no 
Dr. C. Astill, NSF discussion around 1977 no 
Form EES 304 Page 1 
PATENT OR 
APPLICATION NO. 
NAME OF PUBLICATION DATE TITLE OF INVENTION OR PUBLISHED ARTICLE 
NONE 
16. MAWS AND ADDRESSES OF WITNESSES OF FIRST TEST 
NONE 
17. DATE. PLACE. DESCRIPTION AND RESULTS OF LATER TESTS (name. s,,it 
NONE 
18. IDENTIFY RECORDS OF TESTS AND GIVE PRESENT LOCATION OF RECORDS 
NONE 
19. PRIOR REPORTS OR RECORDS OF INVENTION TO WHICH INVENTION IS RELATED 
NONE 
20. OTHER KNOWN CLOSELY RELATED PATENTS, PATENT APPLICATIONS AND PUBLICATIONS . 
21. EXTENT OF USE PAST. PRESENT AND CONTEMPLATED (Give dates, places and other pertinent detail') 
NONE 
22. DETAILS OF INVENTION HAVE BEEN RELEASED TO THE FOLLOWING COMPANIES OR ACTIVITIES 
NAME AND ADDRESS 
	
INDIVIDUAL OR REPRESENTATIVE 
	
CONTRACT NO. 	 DATE 
NONE 
`3 
BIONATUP/ OF INVENTOR 
	
DATE 
RECORD OF INVENTION - Part II 
11/12/52 
(A tach to Record of Invention Port I) 
This Disclosure of Invention should be written up in the inventoe• own wced• 
and generally should follow the outline given below. Sketches, printa, photos 
and other illustrations •  as well se reports of any nature in which the invention 
is referred to, if available, should form • part of this disclosure and reference 
can be made thereto in the description of construction and operation. 
See Pages 12 and 13 of the Fundamentals of Patent Technology SEES 
Circular No. 20. 
REC. OF 	67 6) 1 CS 
!NV. NO 
  
. INVENTORS NAME IS 
HYLAND Y. L. CHEN 
2. TITLE  OF INVENT ION 
AN OPTIC PROBE OF MYOCARDIAL VIABILITY 
For answers to following questions use remainder of sheet, other side, and attach extra •heets if necessary. 
3. GENERAL PURPOSE OF INVENTION. STATE IN GENERAL 
TERMS THE OBJECTS OF THE INVENTION. 
4. DESCRIBE OLD METHOD(S) IF ANY. OF PERFORMING THE 
FUNCTION OF THE INVENTION. 
5. INDICATE THE DISADVANTAGES OF THE OLD MEANS OR DEVICE(S). 
6. DESCRIBE THE CONSTRUCTION OF YOUR INVENTION, SHOW. 
ING THE CHANGES. ADDITIONS AND IMPROVEMENTS OVER 
THE OLD MEANS OR DEVICES 
7. GIVE DETAILS OF THE OPERATION IF NOT ALREADY 
DESCRIBED UNDER 6. 
8. STATE THE ADVANTAGES OF YOUR INVENTION OVER WHAT 
HAS BEEN DONE BEFORE. 
9. INDICATE ANY ALTERNATE METHODS OF CONSTRUCTION. 
10. IF A JOINT INVENTION. INDICATE  WHAT CONTRIBUTION 
WAS MADE BY FACH INVENTOR. 
11 . FEATURES WHICH ARE BELIEVED TO BE NEW. 
12. AFTER THE DISCLOSURE IS PREPARED. IT SHOULD BE SIGNED BY THE INVENTOR( S) AND THEN READ AND SIGNED AT 
THE BOTTOM OF EACH PAGE BY TWO WITNESSES USING THE FOLLOWING STATEMENT: 
• D I SCLOSED TO AND UNDERSTOOD BY ME THIS 	 DAY OF 	 19_ 
SIGNATURE 	  
n• 	 • 	 :•.1 	 I 	 • 	 :.• 	 • 	 . 
•• 
3. . The purpose of the invention is to spatially pinpoint rigor, resting and active 
regions of myocardium in pathological conditions, such as cardiac infarction, to facili-
tate diagnosis and surgery by using an optic probe which picks up optical signatures 
in birefringence of these different regions. The electric activity of myocardium 
varies significantly with its states, and manifests itself in its birefringent properties 
accordingly. 
4. & 5. 	In the case of open heart surgery for cardial infarction the infarcted regions 
are determined by x-ray angiography. The condition of the myocardium within the 
infarcted region, either rigor (dead), resting (due to lack of oxygen) or active is 
determined by inference or the guess of the surgeon. Finite element methods are under 
development to determine the infarcted region by spotting quantitatively the anomaly 
of the contraction, i.e. determining the condition of certain regions by mechanical 
observation, which is global. 
6. & 7. 	As a laser beam passes through or scatters from muscle proper as an electro- 
magnetic wave, the electrical activities such as membrane polarization and cross bridge 
orientation will differentially retard the field propagation. Thus a polarized laser 
beam will be depolarized. The collected beam will pass through an analyzer and register 
on light detectors to give a resultant time-phase shift curve. The birefringence of 
muscle during the course of contraction can then be probed by the time course of the 
depolarization, producing a distinct optic signature depending on the state of the muscl 
A brief block diagram is attached as an example of a possible engineering design of the 
probe. 
8. This method allows pinpoint (with spatial resolution in the order of 50 pm.) 
determination of muscle viability, thus eliminating the uncertainty inherent in. other 
methods; • . 
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11. 	The optic probe tests muscle viability by a method which is categorically 
different from all classical methods. 
DISCLOSED TO AND UNDERSTOOD BY ME DISCLOSED 10 AND UNIrSTAOD BY a 
ON 	 DAY OF  5 41'4  1974 	ON INS Lir  PR oh  
■4  
INVENTOR 
